The Cost-effectiveness of Celecoxib versus Non-steroidal Anti-inflammatory Drugs plus Proton-pump Inhibitors for Treating Osteoarthritis in Algeria
**Background:** Cyclooxygenase-2 inhibitors such as celecoxib are as effective as non-selective non-steroidal anti-inflammatory drugs (ns-NSAIDs) in the treatment of osteoarthritis (OA), have fewer gastrointestinal side effects, but are more expensive. **Objective:** To evaluate the incremental cos...
Saved in:
Main Authors: | Nadir Hammoumraoui, Sid Ahmed Kherraf, Joaquin Mould-Quevedo, Tarek A. Ismail |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2013-10-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://jheor.org/article/9865-the-cost-effectiveness-of-celecoxib-versus-non-steroidal-anti-inflammatory-drugs-plus-proton-pump-inhibitors-for-treating-osteoarthritis-in-algeria |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness of Apixaban for Stroke Prevention in Patients with Atrial Fibrillation in Algeria
by: Yazid Aoudia, et al.
Published: (2017-05-01) -
Deprescribing proton pump inhibitors
by: Kim Jun Kevin Teh, et al.
Published: (2023-08-01) -
Safety of proton pump inhibitors
by: Ye. A. Losik
Published: (2016-08-01) -
Proton Pump Inhibitors: How Appropriate?
by: Daniel C Sadowski
Published: (2000-01-01) -
Proton pump inhibitor leaflets: Is there information on deprescribing?
by: Marcus Vinícius Lopes Campos, et al.
Published: (2025-01-01)